Ressing ME - Search Results

1

Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses.

Verweij MC, Ressing ME, Knetsch W, Quinten E, Halenius A, van Bel N, Hengel H, Drijfhout JW, van Hall T, Wiertz EJ. Verweij MC, et al. Among authors: ressing me. Mol Immunol. 2011 Mar;48(6-7):835-45. doi: 10.1016/j.molimm.2010.12.008. Epub 2011 Feb 2. Mol Immunol. 2011. PMID: 21292324 Free article.

2

Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells.

De Bruijn ML, Schuurhuis DH, Vierboom MP, Vermeulen H, de Cock KA, Ooms ME, Ressing ME, Toebes M, Franken KL, Drijfhout JW, Ottenhoff TH, Offringa R, Melief CJ. De Bruijn ML, et al. Among authors: ressing me. Cancer Res. 1998 Feb 15;58(4):724-31. Cancer Res. 1998. PMID: 9485027

3

Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma.

Ressing ME, de Jong JH, Brandt RM, Drijfhout JW, Benckhuijsen WE, Schreuder GM, Offringa R, Kast WM, Melief CJ. Ressing ME, et al. Eur J Immunol. 1999 Apr;29(4):1292-303. doi: 10.1002/(SICI)1521-4141(199904)29:04<1292::AID-IMMU1292>3.0.CO;2-6. Eur J Immunol. 1999. PMID: 10229097 Free article.

4

The UL41-encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are responsible for down-regulation of MHC class I molecules by bovine herpesvirus 1.

Koppers-Lalic D, Rijsewijk FAM, Verschuren SBE, van Gaans-van den Brink JAM, Neisig A, Ressing ME, Neefjes J, Wiertz EJHJ. Koppers-Lalic D, et al. Among authors: ressing me. J Gen Virol. 2001 Sep;82(Pt 9):2071-2081. doi: 10.1099/0022-1317-82-9-2071. J Gen Virol. 2001. PMID: 11514716

5

Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition.

Ressing ME, van Leeuwen D, Verreck FA, Gomez R, Heemskerk B, Toebes M, Mullen MM, Jardetzky TS, Longnecker R, Schilham MW, Ottenhoff TH, Neefjes J, Schumacher TN, Hutt-Fletcher LM, Wiertz EJ. Ressing ME, et al. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11583-8. doi: 10.1073/pnas.2034960100. Epub 2003 Sep 22. Proc Natl Acad Sci U S A. 2003. PMID: 14504389 Free PMC article.

6

Bovine herpesvirus 1 interferes with TAP-dependent peptide transport and intracellular trafficking of MHC class I molecules in human cells.

Koppers-Lalic D, Rychlowski M, van Leeuwen D, Rijsewijk FA, Ressing ME, Neefjes JJ, Bienkowska-Szewczyk K, Wiertz EJ. Koppers-Lalic D, et al. Among authors: ressing me. Arch Virol. 2003 Oct;148(10):2023-37. doi: 10.1007/s00705-003-0142-5. Arch Virol. 2003. PMID: 14551822

7

Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.

Barel MT, Ressing M, Pizzato N, van Leeuwen D, Le Bouteiller P, Lenfant F, Wiertz EJ. Barel MT, et al. J Immunol. 2003 Dec 15;171(12):6757-65. doi: 10.4049/jimmunol.171.12.6757. J Immunol. 2003. PMID: 14662880

8

Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion.

Ressing ME, van Leeuwen D, Verreck FA, Keating S, Gomez R, Franken KL, Ottenhoff TH, Spriggs M, Schumacher TN, Hutt-Fletcher LM, Rowe M, Wiertz EJ. Ressing ME, et al. J Virol. 2005 Jan;79(2):841-52. doi: 10.1128/JVI.79.2.841-852.2005. J Virol. 2005. PMID: 15613312 Free PMC article.

9

Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing.

Koppers-Lalic D, Reits EA, Ressing ME, Lipinska AD, Abele R, Koch J, Marcondes Rezende M, Admiraal P, van Leeuwen D, Bienkowska-Szewczyk K, Mettenleiter TC, Rijsewijk FA, Tampé R, Neefjes J, Wiertz EJ. Koppers-Lalic D, et al. Among authors: ressing me. Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5144-9. doi: 10.1073/pnas.0501463102. Epub 2005 Mar 25. Proc Natl Acad Sci U S A. 2005. PMID: 15793001 Free PMC article.

10

Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection.

Ressing ME, Keating SE, van Leeuwen D, Koppers-Lalic D, Pappworth IY, Wiertz EJ, Rowe M. Ressing ME, et al. J Immunol. 2005 Jun 1;174(11):6829-38. doi: 10.4049/jimmunol.174.11.6829. J Immunol. 2005. PMID: 15905524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page